VISTAGEN THERAPEUTICS, INC. Increase (Decrease) in Deposit Assets
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase (Decrease) in Deposit Assets of -$46.90 thousand for the 184-month period ending 2014-03-31, per its 10-K filed 2014-06-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositOtherAssets · last filed 2015-06-29
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for the quarter ending 2014-03-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for the quarter ending 2013-12-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for the quarter ending 2012-03-31 was $2.10K, a 76.67% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for the quarter ending 2011-12-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for fiscal 2014 was -$17.90K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for fiscal 2012 was $2.10K, a 53.33% decline from fiscal 2011.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposit assets for fiscal 2011 was $4.50K.
| Period end | Increase (Decrease) in Deposit Assets 3 month | Increase (Decrease) in Deposit Assets 6 month | Increase (Decrease) in Deposit Assets 9 month | Increase (Decrease) in Deposit Assets 12 month | Increase (Decrease) in Deposit Assets 157 month | Increase (Decrease) in Deposit Assets 160 month | Increase (Decrease) in Deposit Assets 163 month | Increase (Decrease) in Deposit Assets 166 month | Increase (Decrease) in Deposit Assets 169 month | Increase (Decrease) in Deposit Assets 172 month | Increase (Decrease) in Deposit Assets 175 month | Increase (Decrease) in Deposit Assets 178 month | Increase (Decrease) in Deposit Assets 181 month | Increase (Decrease) in Deposit Assets 184 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | $0.00 derived: sum of 2 quarters · filed 2015-06-29 | -$17.90K 10-K · filed 2015-06-29 | -$46.90K 10-K · filed 2014-06-25 | ||||||||||
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | -$17.90K 10-Q · filed 2015-02-17 | -$46.90K 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | -$17.90K 10-Q · filed 2014-11-19 | -$46.90K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | -$29.00K 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | -$29.00K 10-K · filed 2013-07-18 | |||||||||||||
| 2012-12-31 | -$29.00K 10-Q · filed 2013-02-14 | |||||||||||||
| 2012-09-30 | -$29.00K 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | -$29.00K 10-Q · filed 2012-08-14 | |||||||||||||
| 2012-03-31 | $2.10K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18 | $2.10K derived: sum of 2 quarters · filed 2013-07-18 | $2.10K 10-K · filed 2013-07-18 | -$29.00K 10-K · filed 2012-07-02 | ||||||||||
| 2011-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | $31.14K 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | $31.14K 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $31.14K 10-Q · filed 2011-08-22 | |||||||||||||
| 2011-03-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02 | $7.50K derived: sum of 2 quarters · filed 2012-07-02 | $6.00K derived: sum of 3 quarters · filed 2012-07-02 | $4.50K 10-K · filed 2012-07-02 | ||||||||||
| 2010-12-31 | -$1.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | -$3.00K derived: sum of 2 quarters · filed 2012-02-14 | -$4.50K 10-Q · filed 2012-02-14 | |||||||||||
| 2010-09-30 | -$1.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | -$3.00K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | -$1.50K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |